Suppr超能文献

口服含有益生菌植物乳杆菌 299v 和油橄榄标准化提取物的颗粒来提高橄榄苦苷向羟基酪醇的体内转化率。

Improving in vivo conversion of oleuropein into hydroxytyrosol by oral granules containing probiotic Lactobacillus plantarum 299v and an Olea europaea standardized extract.

机构信息

Department of Agricultural Sciences, University of Naples Federico II, Via Università 100, 80055, Portici, Naples, Italy.

Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, 80131 Napoli, Italy.

出版信息

Int J Pharm. 2018 May 30;543(1-2):73-82. doi: 10.1016/j.ijpharm.2018.03.013. Epub 2018 Mar 8.

Abstract

This study reports novel food-grade granules for co-delivery of L. plantarum 299v and a standardized extract of Olea europaea leaves (Phenolea®) as oral carrier of probiotics and hydroxytyrosol. Different granule formulations containing either L. plantarum 299v (Lac), or the olive leave extract (Phe) or their combination (Lac-Phe) have been successfully produced through wet granulation employing excipients generally regarded as safe as granulating/binding agents. L. plantarum cells withstood the manufacturing process and were stable upon storage at 4 °C for more than 6 months. In vitro dissolution studies in simulated gastro-intestinal fluids showed the capability of the granules to rapidly dissolve and deliver both olive leave phenols and living L. plantarum cells. In simulated digestion conditions, Lac and Lac-Phe granules protected L. plantarum against the harsh environment of the gastro-intestinal tract. Co-administration of Lac and Phe oral granules to healthy mice provided for higher amounts of hydroxytyrosol in urines as compared to Phe granules alone, suggesting that L. plantarum 299v boosted in vivo conversion of oleuropein to hydroxytyrosol. On the other hand, PCR-assisted profiling of the Lactobacillus population in faeces obtained from mice treated with Lac or Lac plus Phe confirmed that the probiotic arrived alive to colon and was there able to exert a sort of perturbing effect on the climax colonic microflora. Overall, these results pave the way towards the development of a nutraceutical useful for combined delivery of bioactive hydroxytyrosol and probiotics to colon site.

摘要

本研究报告了一种新型的食品级颗粒,用于共递送植物乳杆菌 299v 和标准化的油橄榄叶提取物(Phenolea®),作为益生菌和羟基酪醇的口服载体。通过湿法造粒成功制备了含有植物乳杆菌 299v(Lac)、橄榄叶提取物(Phe)或其组合(Lac-Phe)的不同颗粒制剂,所用辅料均被视为安全的造粒/粘合剂。植物乳杆菌细胞能够耐受制造过程,并在 4°C 下储存超过 6 个月时保持稳定。在模拟胃肠液中的体外溶解研究表明,这些颗粒具有快速溶解并释放橄榄叶酚和活菌的能力。在模拟消化条件下,Lac 和 Lac-Phe 颗粒能够保护植物乳杆菌免受胃肠道恶劣环境的影响。将 Lac 和 Phe 口服颗粒共同给予健康小鼠,与单独给予 Phe 颗粒相比,尿液中羟基酪醇的含量更高,这表明植物乳杆菌 299v 促进了橄榄苦苷向羟基酪醇的体内转化。另一方面,用 Lac 或 Lac 加 Phe 处理的小鼠粪便中乳酸菌种群的 PCR 分析证实,益生菌能够活着到达结肠,并在那里对结肠高峰菌群产生一种干扰作用。总的来说,这些结果为开发一种用于同时递送至结肠部位的生物活性羟基酪醇和益生菌的营养保健品铺平了道路。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验